» Articles » PMID: 19158353

RAGE-induced Cytosolic ROS Promote Mitochondrial Superoxide Generation in Diabetes

Abstract

Damaged mitochondria generate an excess of superoxide, which may mediate tissue injury in diabetes. We hypothesized that in diabetic nephropathy, advanced glycation end-products (AGEs) lead to increases in cytosolic reactive oxygen species (ROS), which facilitate the production of mitochondrial superoxide. In normoglycemic conditions, exposure of primary renal cells to AGEs, transient overexpression of the receptor for AGEs (RAGE) with an adenoviral vector, and infusion of AGEs to healthy rodents each induced renal cytosolic oxidative stress, which led to mitochondrial permeability transition and deficiency of mitochondrial complex I. Because of a lack of glucose-derived NADH, which is the substrate for complex I, these changes did not lead to excess production of mitochondrial superoxide; however, when we performed these experiments in hyperglycemic conditions in vitro or in diabetic rats, we observed significant generation of mitochondrial superoxide at the level of complex I, fueled by a sustained supply of NADH. Pharmacologic inhibition of AGE-RAGE-induced mitochondrial permeability transition in vitro abrogated production of mitochondrial superoxide; we observed a similar effect in vivo after inhibiting cytosolic ROS production with apocynin or lowering AGEs with alagebrium. Furthermore, RAGE deficiency prevented diabetes-induced increases in renal mitochondrial superoxide and renal cortical apoptosis in mice. Taken together, these studies suggest that AGE-RAGE-induced cytosolic ROS production facilitates mitochondrial superoxide production in hyperglycemic environments, providing further evidence of a role for the advanced glycation pathway in the development and progression of diabetic nephropathy.

Citing Articles

The Potential Role of Advanced Glycation End Products in the Development of Kidney Disease.

Ma Y, Wang X, Lin S, King L, Liu L Nutrients. 2025; 17(5).

PMID: 40077627 PMC: 11902189. DOI: 10.3390/nu17050758.


Skeletal muscle atrophy and dysfunction in obesity and type-2 diabetes mellitus: Myocellular mechanisms involved.

Castillo I, Argiles J, Rueda R, Ramirez M, Pedrosa J Rev Endocr Metab Disord. 2025; .

PMID: 40064750 DOI: 10.1007/s11154-025-09954-9.


Exploring Endothelial Cell Dysfunction's Impact on the Brain-Retina Microenvironment Connection: Molecular Mechanisms and Implications.

Shah W, Gong Y, Qiao X, Lu Y, Ding Y, Zhang Z Mol Neurobiol. 2025; .

PMID: 39904964 DOI: 10.1007/s12035-025-04714-x.


TFAM and Mitochondrial Protection in Diabetic Kidney Disease.

Yu S, Lu X, Li C, Han Z, Li Y, Zhang X Diabetes Metab Syndr Obes. 2024; 17:4355-4365.

PMID: 39588133 PMC: 11586499. DOI: 10.2147/DMSO.S487815.


Targeting endothelin signaling in podocyte injury and diabetic nephropathy-diabetic kidney disease.

Empitu M, Rinastiti P, Kadariswantiningsih I J Nephrol. 2024; 38(1):49-60.

PMID: 39302622 DOI: 10.1007/s40620-024-02072-w.


References
1.
Wendt T, Tanji N, Guo J, Kislinger T, Qu W, Lu Y . RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am J Pathol. 2003; 162(4):1123-37. PMC: 1851245. DOI: 10.1016/S0002-9440(10)63909-0. View

2.
Bierhaus A, Haslbeck K, Humpert P, Liliensiek B, Dehmer T, Morcos M . Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest. 2004; 114(12):1741-51. PMC: 535062. DOI: 10.1172/JCI18058. View

3.
Forbes J, Yee L, Thallas V, Lassila M, Candido R, Jandeleit-Dahm K . Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis. Diabetes. 2004; 53(7):1813-23. DOI: 10.2337/diabetes.53.7.1813. View

4.
Beyer R . An analysis of the role of coenzyme Q in free radical generation and as an antioxidant. Biochem Cell Biol. 1992; 70(6):390-403. DOI: 10.1139/o92-061. View

5.
Broekemeier K, DEMPSEY M, Pfeiffer D . Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J Biol Chem. 1989; 264(14):7826-30. View